Heron Bay Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Heron Bay Capital Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,034	Closed	-$743K	–	108
2023 Q2	$743K	Buy	1,034 +11	+1%	+$8.48K	0.21%	52
2023 Q1	$841K	Buy	+1,023	New	+$772K	0.33%	48
2022 Q1	–	Sell	-3,686	Closed	-$2.33M	–	73
2021 Q4	$2.33M	Buy	3,686 +42	+1%	+$25.8K	1.15%	37
2021 Q3	$2.21M	Buy	3,644 +955	+36%	+$593K	1.14%	32
2021 Q2	$1.5M	Buy	2,689 +59	+2%	+$29.9K	0.83%	43
2021 Q1	$1.24M	Buy	2,630 +464	+21%	+$226K	0.74%	47
2020 Q4	$1.05M	Buy	+2,166	New	+$1.17M	0.68%	49

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Heron Bay Capital Management's REGN Position: Q3 2023 in Review

Heron Bay Capital Management sold out of Regeneron Pharmaceuticals (REGN) in Q3 2023, closing a stake of 1,034 shares — an estimated $743K sold.

Heron Bay Capital Management first reported a position in REGN in Q4 2020 and held it in 7 quarters. The position peaked at $2.33M in Q4 2021. 1,177 funds tracked by Wall St. Rank hold REGN as of Q3 2023.

Heron Bay Capital Management reported no remaining Regeneron Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
Heron Bay Capital Management sold 1,034 Regeneron Pharmaceuticals shares in Q3 2023, an estimated $743K.
Heron Bay Capital Management first reported a position in Regeneron Pharmaceuticals in Q4 2020 and held it in 7 quarters.
Heron Bay Capital Management's Regeneron Pharmaceuticals position peaked at $2.33M in Q4 2021.
1,177 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2023.

Based on Heron Bay Capital Management's 13F filing for Q3 2023, filed 1 Nov 2023.